Prucalopride Succinate

/Prucalopride Succinate
Prucalopride Succinate 2020-07-11T20:19:00+08:00

Prucalopride Succinate

Prucalopride琥珀酸盐是5-HT4受体选择高亲和性激动剂,对5-HT4a和5-HT4b的pKi值分别为8.6和8.1。

中文名:琥珀酸普卡必利

英文名:Prucalopride Succinate; R-108512

CAS 号: 179474-85-2

分子式:C₂₂H₃₂ClN₃O₇

分子量:485.96

纯度:>98.0%

DescriptionPrucalopride succinate is a selective, high affinity 5-HT4 receptor agonist with pKi of 8.6/8.1 for 5-HT4a/4b. IC50 value: Target: 5-HT4 agonist in vitro: Prucalopride was a 5-HT(4) receptor agonist in the guinea-pig colon, as it induced contractions (pEC(50)=7.48+/-0.06; insensitive to a 5-HT(2A) or 5-HT(3) receptor antagonist, but inhibited by a 5-HT(4) receptor antagonist) as well as the facilitation of electrical stimulation-induced noncholinergic contractions (blocked by a 5-HT(4) receptor antagonist). Prucalopride did not cause relevant inhibition of 5-HT(2A), 5-HT(2B), or 5-HT(3), motilin or cholecystokinin (CCK(1)) receptor-mediated contractions, nor nicotinic or muscarinic acetylcholine receptor-mediated contractions, up to 10 microM [1]. in vivo: Rat microdialysis studies revealed that prucalopride maximally increased ACh and histamine levels in the prefrontal cortex at 5 and 10 mg/kg, whereas PRX-03140 significantly increased cortical histamine levels at 50 mg/kg, failing to affect ACh release at doses lower than 150 mg/kg [2].
Target5-HT4A Receptor;5-HT4B Receptor
References[1]. Briejer MR, et al. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol. 2001 Jun 29;423(1):71-83.

[2]. Johnson DE, et al. The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations. J Pharmacol Exp Ther. 2012 Jun;341(3):681-91.
电子邮箱
  • enquiry@bestbiochem.com
QQ客服
  • 1652852700 点击这里给我发消息
技术转让
  • 医药化工类技术转让平台